This study aims to establish a prospective cohort of developing pancreas cancer and surveillance MRI protocol. With the focused surveillance protocol, we perform surveillance for pancreas cancer for five years to estimate the risk of pancreas cancer and the clinical feasibility of the surveillance MRI.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SCREENING
Masking
NONE
Enrollment
200
Annual non-contrast PB MRI.
K-ras and GNAS mutation test. Being performed once as a baseline test at the enrollment.
Any of followings: scheduled CECT, MRI, USG, EUS, tumor marker (CA 19-9) during the study period.
Seoul National University Hospital
Seoul, South Korea
Detection of pancreas cancer
number of detected pancreas cancer (resectable \& BRPC only) in surveillance MRI.
Time frame: 1 year after the last surveillance MRI.
Scan time of abbreviated PB MRI for surveillance
table time, in-room time measurement for feasibility
Time frame: 1 month after the first surveillance MRI.
Estimation of pancreas cancer risk
rate of developing pancreas cancer during the study period
Time frame: 1 year after the last surveillance MRI.
Detection of pancreas cancer
number of detected pancreas cancer of all stages (resectable, BRPC, LAPC, metastatic) in surveillance MRI.
Time frame: 1 year after the last surveillance MRI.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.